BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28892090)

  • 21. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
    Tang Z; Hecker CM; Scheschonka A; Betz H
    FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive and negative regulation of APP amyloidogenesis by sumoylation.
    Li Y; Wang H; Wang S; Quon D; Liu YW; Cordell B
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):259-64. PubMed ID: 12506199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SUMOylation in carcinogenesis.
    Bettermann K; Benesch M; Weis S; Haybaeck J
    Cancer Lett; 2012 Mar; 316(2):113-25. PubMed ID: 22138131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Crosstalk between the PP2A and SUMO Pathways Revealed by Analysis of STUbL Suppressor, razor 1-1.
    Nie M; Arner E; Prudden J; Schaffer L; Head S; Boddy MN
    PLoS Genet; 2016 Jul; 12(7):e1006165. PubMed ID: 27398807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping.
    Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1218-23. PubMed ID: 26810265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1).
    Campbell LA; Faivre EJ; Show MD; Ingraham JG; Flinders J; Gross JD; Ingraham HA
    Mol Cell Biol; 2008 Dec; 28(24):7476-86. PubMed ID: 18838537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
    Mabb AM; Wuerzberger-Davis SM; Miyamoto S
    Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation.
    Albuquerque CP; Yeung E; Ma S; Fu T; Corbett KD; Zhou H
    PLoS One; 2015; 10(12):e0143810. PubMed ID: 26633173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
    Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
    Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functions of SUMO in the Maintenance of Genome Stability.
    Zilio N; Eifler-Olivi K; Ulrich HD
    Adv Exp Med Biol; 2017; 963():51-87. PubMed ID: 28197906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pax8 protein stability is controlled by sumoylation.
    de Cristofaro T; Mascia A; Pappalardo A; D'Andrea B; Nitsch L; Zannini M
    J Mol Endocrinol; 2009 Jan; 42(1):35-46. PubMed ID: 18974227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitotic kinase Aurora-B is regulated by SUMO-2/3 conjugation/deconjugation during mitosis.
    Ban R; Nishida T; Urano T
    Genes Cells; 2011 Jun; 16(6):652-69. PubMed ID: 21554500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of cellular SUMO and SUMO-ubiquitin hybrid conjugates.
    Schnellhardt M; Uzunova K; Bade VN; Krause A; Weisshaar SR; Praefcke GJ; Dohmen RJ
    Methods Mol Biol; 2012; 832():81-92. PubMed ID: 22350877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SUMOylation attenuates c-Maf-dependent IL-4 expression.
    Lin BS; Tsai PY; Hsieh WY; Tsao HW; Liu MW; Grenningloh R; Wang LF; Ho IC; Miaw SC
    Eur J Immunol; 2010 Apr; 40(4):1174-84. PubMed ID: 20127678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
    Niedenthal R
    Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly sensitive assays for SUMOylation and small ubiquitin-like modifier-dependent protein-protein interactions.
    Rouleau N; Wang J; Karras L; Andrews E; Bielefeld-Sevigny M; Chen Y
    Anal Biochem; 2008 Apr; 375(2):364-6. PubMed ID: 18154725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.
    Wang M; Sang J; Ren Y; Liu K; Liu X; Zhang J; Wang H; Wang J; Orian A; Yang J; Yi J
    Protein Cell; 2016 Jan; 7(1):63-77. PubMed ID: 26511642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversification of SUMO-activating enzyme in Arabidopsis: implications in SUMO conjugation.
    Castaño-Miquel L; Seguí J; Manrique S; Teixeira I; Carretero-Paulet L; Atencio F; Lois LM
    Mol Plant; 2013 Sep; 6(5):1646-60. PubMed ID: 23482370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SUMOylation and cell signalling.
    Andreou AM; Tavernarakis N
    Biotechnol J; 2009 Dec; 4(12):1740-52. PubMed ID: 19946876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins.
    Rodríguez JA
    Semin Cancer Biol; 2014 Aug; 27():11-9. PubMed ID: 24704338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.